Campbell's stock downgraded as company must 'work harder for less growth'
By Steve Gelsi
D.A. Davidson cuts Campbell Co.'s rating to neutral from buy, citing a shift by consumers to private-label foods
Campbell Co.'s stock drew a downgrade to neutral from buy on Friday, as the food giant faces stiffer competition from consumers shifting to less expensive private-label foods.
D.A. Davidson analyst Brian Holland said Campbell's (CPB) stock-price advance is outpacing the fundamentals of its business.
"Food companies will have to work harder for less growth in a more competitive environment," Holland said in a research note.
The company faces "consumer pressures, improved supply chain, and private label recovery," he said.
Private-label products are usually store brands or other consumer products that typically sell for less than major consumer brands.
Campbell faces "near-term volume pressure and minimal price contribution weighing on the top line, while marketing and selling reinvestment constrains margins," Holland said.
While the current challenges are cyclical and likely to change when economic conditions improve, Holland doesn't see a near-term catalyst for Campbell.
With a year-to-date stock gain of 14.3%, Campbell's stock has performed better than that of most large food companies, with the exception of WK Kellogg Co. (KLG).
"Given the company has levered advertising more than any food company over the past three years, and as industrywide demand headwinds persist, we see risk reinvestment will not yield improved sales and profits - at least over the next 12 months," Holland said.
Holland reiterated a 12-month price target of $51 a share for Campbell.
Campbell's stock fell 20 cents to $49.22 a share on Friday.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-27-24 1424ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks